II
PTCT icon

Inspire Investing’s PTC Therapeutics PTCT Stock Holding History

Inspire Investing’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$515K Buy
7,559
+1,419
+23% +$100K 0.03% 650
2025
Q4 		$466K Sell
6,140
-1,379
-18% -$100K 0.04% 611
2025
Q3 		$461K Sell
7,519
-424
-5% -$22.1K 0.04% 358
2025
Q2 		$388K Buy
7,943
+1,061
+15% +$50.4K 0.04% 647
2025
Q1 		$351K Sell
6,882
-2,245
-25% -$112K 0.04% 340
2024
Q4 		$412K Sell
9,127
-1,912
-17% -$81.8K 0.05% 354
2024
Q3 		$410K Sell
11,039
-506
-4% -$16.9K 0.04% 721
2024
Q2 		$353K Sell
11,545
-669
-5% -$21.7K 0.04% 486
2024
Q1 		$355K Sell
12,214
-1,833
-13% -$51.3K 0.04% 752
2023
Q4 		$387K Buy
14,047
+267
+2% +$6.11K 0.04% 438
2023
Q3 		$309K Buy
13,780
+74
+0.5% +$2.75K 0.04% 446
2023
Q2 		$557K Buy
+13,706
New +$671K 0.07% 275

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Inspire Investing's PTCT Position: Q1 2026 in Review

Inspire Investing increased its PTC Therapeutics (PTCT) stake by 23% in Q1 2026, buying an estimated $100K and bringing the position to 7,559 shares worth $515K. The position accounts for 0.03% of the portfolio, ranked #650.

Inspire Investing first reported a position in PTCT in Q2 2023 and has held it in 12 quarters since. The position peaked at $557K in Q2 2023. 350 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Inspire Investing held 7,559 shares of PTC Therapeutics worth $515K as of Q1 2026.
  • Inspire Investing bought 1,419 PTC Therapeutics shares in Q1 2026, an estimated $100K.
  • PTC Therapeutics made up 0.03% of Inspire Investing's portfolio in Q1 2026, its #650 holding.
  • Inspire Investing first reported a position in PTC Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • Inspire Investing's PTC Therapeutics position peaked at $557K in Q2 2023.
  • 350 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.